PGProgyny, Inc. PGNY · NASDAQ
$27.84 +3.65% (+$0.98)
- Market cap
- $2.06B
- Enterprise value
- $1.94B
- P/E
- 26.2x
- Forward P/E
- 17.9x
- PEG
- 4.6x
- P/S
- 1.6x
- P/FCF
- 9.5x
- EV/EBITDA
- 15.2x
- ROIC
- 15.3%
- Gross margin
- 24.6%
- Net margin
- 6.0%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -1.0x
- Beta
- 1.02
- Free float
- 91.5%
About the company
Progyny, Inc. (Progyny) is an American company specializing in providing specialized services in the field of reproductive health. The company offers a range of programs and services for couples and individuals seeking assistance with reproductive issues, including infertility treatment. Progyny focuses on supporting and coordinating treatment, which may include assisted reproduction, in vitro fertilization (IVF), and other methods. Their goal is to help people achieve healthy pregnancies and families. Progyny, Inc. shares may be suitable for investors seeking opportunities in the healthcare and reproductive health sector.
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Pete Anevski
Employees
846
Headquarters
New York City
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number